Skip to main navigation Skip to search Skip to main content

miRNAS AS NOVEL ANTIDEPRESSANT TARGETS: CONVERGING EFFECTS OF ACUTE KETAMINE, ELECTROCONVULSIVE SHOCK THERAPY AND CHRONIC FLUOXETINE TREATMENTS

  • Icahn School of Medicine at Mount Sinai

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish (Ireland)
Publication statusPublished - 2011

Cite this